Skip to the content
Investors
Careers
Seek Labslogo darklogo light
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Seek Labs
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Seek Labs
  • About Us
  • Innovations
    • Therapeutics
    • Diagnostics
      • Point of Care Use Cases
      • Key Innovations
      • Communication
      • SeekIt™
  • Seekers
  • Partnering
  • News
  • Contact Us
  • Investors
  • Careers
Electron micrograph image of foot-and-mouth disease virus particles.
Featured Therapeutics

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic September 9, 2025 Salt Lake City, UT (Business Wire) &#8211

Bridget Baldwin
September 9, 2025
0 Comments
A close-up of a mosquito standing on a light-colored fabric surface.
Featured Therapeutics

Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™

Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™, Accelerating Therapeutic Discovery for Chikungunya, West Nile Virus, and Zika August 5, 2025 Salt L

Bridget Baldwin
August 5, 2025
0 Comments
Veterinarian wearing biosecurity suit holding a pig inside a swine farm facility
Featured Therapeutics

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains July 22, 2025 SALT LA

Bridget Baldwin
July 22, 2025
0 Comments
3D illustration of respiratory syncytial virus (RSV) particles with spike-like surface proteins.
Corporate Featured Therapeutics

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) July 8, 2025 Read the Medium Article from our CEO, Jared Bauer

Bridget Baldwin
July 8, 2025
0 Comments
Digital illustration of a computer monitor displaying a glowing brain-shaped circuit, symbolizing artificial intelligence.
Featured Therapeutics

Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks

Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks June 23, 2025 Read the Medium Article from o

Bridget Baldwin
June 23, 2025
0 Comments
Computer monitor showing BioSeeker platform interface with a list of pathogens and status updates
Featured Therapeutics

Seek Labs Unveils BioSeeker™

Seek Labs Unveils BioSeeker™ Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions June 10, 2025 R

Bridget Baldwin
June 10, 2025
0 Comments
Featured Therapeutics

Seek Labs Joins Global African Swine Fever Research Alliance (GARA)

Seek Labs Joins Global African Swine Fever Research Alliance (GARA) September 16, 2024 Seek Labs is excited to announce its participation in the Global African Swine Fever Research

Bridget Baldwin
September 16, 2024
Event banner for North American Online Workshop on emerging and zoonotic influenza, African swine fever, and bovine tuberculosis, June 11–13, 2024
Featured Therapeutics

Doug Gladue, VP of Veterinary Pharmaceutical Development, Presents at PROCINORTE Priority Animal Diseases 2024 Workshop

Doug Gladue, VP of Veterinary Pharmaceutical Development, Presents at PROCINORTE Priority Animal Diseases 2024 Workshop June 12, 2024 Today, Dr. Douglas Gladue, VP of Veterinary Ph

Bridget Baldwin
June 12, 2024
Professional headshot of Doug Gladue in a suit and tie against a neutral background
Corporate Featured Therapeutics

Seek Labs Appoints Renowned African Swine Fever Researcher, Douglas Gladue, PhD, as Vice President of Veterinary Pharmaceutical Development

Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development June 3, 2024 SALT LAKE CITY, UTAH, June 3,

Bridget Baldwin
June 3, 2024
Professional headshot of Alison O’Mahony in a white jacket against a dark blue background
Corporate Featured Therapeutics

Alison O’Mahony Named One of 30 Women to Watch 2024 by Utah Business

Dr. Alison O’Mahony, Vice President of Pharmaceutical Research, Named One of 30 Women to Watch 2024 by Utah Business May 30, 2024 This week, Alison O’Mahony, VP of Phar

Bridget Baldwin
May 30, 2024

Posts pagination

1 2
350 W 800 N, Suite 220
Salt Lake City, UT 84103
  • About Us
  • Seekers
  • Contact Us
  • Investors
  • Quality Policy
  • Innovations
  • Therapeutics
  • Diagnostics

    By submitting this form, you agree to our Terms of Service and Privacy Policy.

    Multiple Patents Pending | Copyright 2023 All Rights Reserved

    Terms of Service | Privacy Policy

    BioSeeker, PTAP, and SeekIt are investigational platforms currently in preclinical development. Not cleared or approved by the FDA or any other regulatory agency..

    Back to top Drag